Phase II Study With Trastuzumab + Paclitaxel in Locally Advanced HER2+ Tumors or Epirubicin + Taxotere in HER2- Tumors

Clinical trial NCT02307227 · COMPLETED

Trial details

NCT number: NCT02307227
Sponsor: Centro di Riferimento Oncologico - Aviano
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2006-04-01
Primary completion: 2009-04-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.